Contact this trialFirst, we need to learn more about you.
Device
Tan EndoGlide vs Forceps for Reducing Cell Loss in Corneal Transplant
Recruiting1 award
Toronto, Ontario
This trial found that the Tan EndoGlide device causes less damage to cells during corneal transplant surgery, leading to fewer cell losses.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.